Veriheal
AUGUST 18, 2020
Psychosis is a condition that can (negatively) affect the way the brain processes information. Cardiotoxicity is a condition where the heart muscles are damaged and can interrupt blood flow throughout the body. Thus, making synthetic cannabinoids best when avoided. .
Cannabis Law Report
JULY 19, 2021
Psychedelic medicine is a rapidly growing area and could be potential breakthrough therapeutics globally for psychiatric conditions such as depression, post-traumatic stress disorder (PTSD) and addiction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kind Meds (Cannabis Education Blog)
JUNE 7, 2021
From medical use of cannabinoids to nutritional support from hemp seeds, the Cannabis sativa is popular to ease the pain of chronic conditions, create strong fabrics, help lessen effects of anxiety and depression, and, of course, for a recreational high in 17 states and the District of Columbia. Cannabis in Many Forms.
Cannabis Law Report
JUNE 22, 2021
.” Tej Virk will join Akanda as CEO from Khiron Life Sciences (TSX-V: KHRN) (OTC: KHRNF) (“Khiron”), where he was President and Managing Director, Europe , establishing Khiron’s medical and consumer packaged goods business in the region. Mojela has received numerous accolades for her leadership.
Meadow
DECEMBER 24, 2017
And then another question of okay, so you’re a retailer, you’ve got flour in your inventory, what are you going to do with it if it’s not packaged? And so as most retailers do currently, they package it themselves, they’re going to be able to do that with what’s in their inventory currently. We’ll talk more.
The Cannigma
FEBRUARY 11, 2021
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I And what about conditions? I know how to collect data.
Cannabis Law Report
OCTOBER 29, 2019
Dr. Wakshlag and ElleVet are currently conducting additional clinical trials to demonstrate the efficacy of ElleVet hemp CBD/CBDA in other important conditions. Pharmacokinetic variables were estimated by means of non-compartmental analysis, utilizing a pharmacokinetic software package (PK Solution, version 2.0, Wakshlag, DVM, Ph.D.,
Expert insights. Personalized for you.
52 
Let's personalize your content